William Blair Upgrades Neumora Therapeutics to Outperform

Benzinga Newsdesk Feb 17, 2026 8 months ago

NewsUpgradesAnalyst Ratings

William Blair analyst Myles Minter upgrades Neumora Therapeutics (NASDAQ:NMRA) from Market Perform to Outperform.